Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
4
×
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
calcitonin gene-related peptide
drugs
eli lilly
eptinezumab
erenumab
fremanezumab
galcanezumab
migraine research foundation
novartis
roche
What
drug
4
×
fda
new
4
×
approval
approved
class
medicine
migraine
oral
won
amgen
arguments
atrophy
big
cancer
candidates
commercialized
companies
competitors
daily
decades
deeper
developed
dna
drugs
evrysdi
fingerprint
friday
genetic
gets
going
green
head
home
intended
lights
liquid
make
matter
medicines
Language
unset
Current search:
drug
×
fda
×
new
×
" san francisco top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines